FDA Approves GARDASIL(R) For Use In Boys And Young Men

Merck & Co., Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved GARDASIL® [Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant] for use in boys and men 9 through 26 years of age for the prevention of genital warts caused by human papillomavirus (HPV) types 6 and 11. FDA approval is the first step in an important two-step process.

Sponsored by Internet Pharmacy - Indian Pharmacy, an online pharmacy supplies more than 600 quality generic medications, free prescription, worldwide shipping.

Canadian Pharmacy canada pharmacy

Related posts:

  1. FDA Approves New Indication For Gardasil To Prevent Genital Warts In Men And Boys FDA Approves New Indication For Gardasil To Prevent Genital Warts In Men And Boys The U.S. Food and Drug Administration approved use of the vaccine Gardasil for the prevention of...
  2. FDA Advisory Committee Recommends Approval For Use Of GARDASIL(R) In Boys And Men FDA Advisory Committee Recommends Approval For Use Of GARDASIL(R) In Boys And Men Merck & Co., Inc. announced that the U.S. Food and Drug Administration’s (FDA) Vaccines and Related Biological...
  3. CDC Panel Recommends HPV Vaccine Cervarix For Girls, Optional Gardasil Vaccination For Boys CDC Panel Recommends HPV Vaccine Cervarix For Girls, Optional Gardasil Vaccination For Boys The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices on Wednesday recommended GlaxoSmithKline’s human...